Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Thomas D, Meek"'
Autor:
Jiyun Zhu, Linfeng Li, Aleksandra Drelich, Bala C. Chenna, Drake M. Mellott, Zane W. Taylor, Vivian Tat, Christopher Z. Garcia, Ardala Katzfuss, Chien-Te K. Tseng, Thomas D. Meek
Publikováno v:
Frontiers in Chemistry, Vol 10 (2022)
Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these prote
Externí odkaz:
https://doaj.org/article/83d373bc5b624e3288eb3d76ea8c126b
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 2, p e0009926 (2022)
Human African Trypanosomiasis (HAT), also known as sleeping sickness, is a Neglected Tropical Disease endemic to 36 African countries, with approximately 70 million people currently at risk for infection. Current therapeutics are suboptimal due to to
Externí odkaz:
https://doaj.org/article/8ecb1189bbf841f5bef22a3e772a75bd
Autor:
Kayla Glockzin, Demetrios Kostomiris, Yacoba V. T. Minnow, Kajitha Suthagar, Keith Clinch, Sinan Gai, Joshua N. Buckler, Vern L. Schramm, Peter C. Tyler, Thomas D. Meek, Ardala Katzfuss
Publikováno v:
Biochemistry. 61:2088-2105
Autor:
Anthony J. O’Donoghue, Michael C Yoon, Max J. Bedding, Vivian Hook, Pavla Fajtová, Arthur H Tang, Mark Larance, Linfeng Li, Chien-Te Tseng, Stuart Turville, James H. McKerrow, Dustin Pwee, Laura Beretta, Alexander Stoye, Danielle E. Skinner, William H. Gerwick, Anneliese S. Ashhurst, Thomas D. Meek, Anupriya Aggarwal, Aleksandra Drelich, Richard J. Payne
Publikováno v:
bioRxiv
Cathepsin L is a key host cysteine protease utilized by coronaviruses for cell entry and is a promising drug target for novel antivirals against SARS-CoV-2. The marine natural product gallinamide A and several synthetic analogues were identified as p
Autor:
Scott A. Cameron, Lawrence Harris, Arthur Laganowsky, Zahra Moghadamchargari, Dan Torres, James C. Sacchettini, Inna Krieger, Thomas D. Meek, Drake M. Mellott
Publikováno v:
Journal of the American Chemical Society. 143:17666-17676
The isocitrate lyase paralogs of Mycobacterium tuberculosis (ICL1 and 2) are essential for mycobacterial persistence and constitute targets for the development of antituberculosis agents. We report that (2R,3S)-2-hydroxy-3-(nitromethyl)succinic acid
Autor:
Thomas D. Meek
Publikováno v:
Burger's Medicinal Chemistry and Drug Discovery
Autor:
Aleksandra Drelich, Miriam A. Giardini, Pavla Fajtová, Drake M. Mellott, Vivian Hook, Thomas D. Meek, Jason C. Hsu, Demetrios H. Kostomiris, Aaron F. Carlin, Frank M. Raushel, Klaudia I. Kocurek, Jair L. Siqueira-Neto, Zane W. Taylor, Anthony J. O’Donoghue, Felix W Frueh, Jiyun Zhu, Ardala Katzfuss, Chien Te K. Tseng, Sungjun Beck, Hong Wang, Brett L. Hurst, Laura Beretta, Ken Hirata, James H. McKerrow, Alex E. Clark, Linfeng Li, Daniel C Maneval, Danielle E. Skinner, Balachandra Chenna, Vivian Tat, Michael C Yoon
Publikováno v:
ACS Chemical Biology. 16:642-650
Host-cell cysteine proteases play an essential role in the processing of the viral spike protein of SARS coronaviruses. K777, an irreversible, covalent inactivator of cysteine proteases that has recently completed phase 1 clinical trials, reduced SAR
Autor:
Thomas D. Meek, Drake M. Mellott, Truc Viet Pham, Inna Krieger, Zahra Moghadamchargari, Kevin Chen, James C. Sacchettini, Arthur Laganowsky
Publikováno v:
ACS Chemical Biology. 16:463-470
The isocitrate lyases (ICL1/2) are essential enzymes of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. At present, no ICL1/2 inhibitors have progressed to clinical evaluation, despite extensive drug discovery efforts. Herein,
Autor:
Zane W. Taylor, Marcetta Y. Darensbourg, Drake M. Mellott, Thomas D. Meek, Christopher R DeLaney, Ardala Katzfuss, Jiyun Zhu, D Chase Pectol
Publikováno v:
Chemical Communications. 57:8352-8355
By repurposing DNICs designed for other medicinal purposes, the possibility of protease inhibition was investigated in silico using AutoDock 4.2.6 (AD4) and in vitro via a FRET protease assay. AD4 was validated as a predictive computational tool for
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 376:106-117
The active form of transforming growth factor-β1 (TGF-β1) plays a key role in potentiating fibrosis. TGF-β1 is sequestered in an inactive state by a latency-associated glycopeptide (LAP). Sialidases (also called neuraminidases (NEU)) cleave termin